We fund discovery research If you have a bold idea that could help prevent, diagnosis or treat cancer, we may be able to support you with a project grant. Since our foundation in 1979, we have invested in nearly 2,000 research projects around the world. “Cancer Research UK funds nearly 50% of the cancer research in the UK and making cuts to research funding is the most difficult decision we have had to make. About AACR Research Funding. Who pays for science? Cancer Research: Where the Funding Goes. See where we are currently funding ongoing research and clinical trials. Today, we all do. Global research efforts to fight cancer have been ongoing since the 1970's to turn this disease into a chronic, instead of a fatal one. Most scientific research is funded by government grants (e.g., from the National Science Foundation, the National Institutes of Health, etc. ). The funding may be used for the applicant’s own salary, the salary of a research assistant, and/or research materials for the specified project. Research in this area continues under Horizon 2020.
In a Journal of the American Medical Association (JAMA) study published in January 2010, the largest study to date to attempt to quantify U.S. funding of biomedical research by the pharmaceutical industry, government, and private sources, researchers estimate that U.S. biomedical research currently stands at about over $100 billion annually. Certain types of cancer, like breast cancer, tend to attract more research funding than others. We don’t do so lightly. Since 1993, the AACR has awarded more than $460 million in grants to more than 800 scientists for research projects that aim to advance the understanding and treatment of cancer. ), companies doing research and development, and non-profit foundations (e.g., the Breast Cancer Research Foundation, the David and Lucile Packard Foundation, etc. CRI-funded scientists are making cancer immunology breakthroughs around the world. The WHO Global Initiative for Childhood Cancer, which involves development of a WHO technical package to help scale-up capacities within national health systems, will be achieved with support from a host of partners. Many Cure Cancer researchers who received this funding early in their careers are now among Australia and the world’s most prominent cancer researchers. The past years have witnessed a dramatic progress in understanding the molecular mechanisms at work in the transformation of a normal cell into a cancer cell. We have worked hard to ensure the cuts are limited and give our researchers flexibility in how to make them.